C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular Disease
P.M. Burger(University Medical Center Utrecht), Aernoud T.L. Fiolet(University Medical Center Utrecht), Gert J. de Borst(Reinier de Graaf Hospital), Hendrik M. Nathoe, Maarten J. Cramer(SUNY Downstate Health Sciences University), Arend Mosterd(Werkgroep Cardiologische centra Nederland), Ynte M. Ruigrok(Utrecht University), A. Titia Lely, Martin Teraa(Maine Farmland Trust), Manon G. van der Meer(University Medical Center Utrecht), Marianne C. Verhaar(Utrecht University), Jannick A N Dorresteijn(Heidelberg University), L. Jaap Kappelle(SUNY Downstate Health Sciences University), Frank L.J. Visseren, Stefan Koudstaal, Niels P. van der Kaaij, Michiel L. Bots(Utrecht University), Paul M. Ridker(Brigham and Women's Hospital), Mariëlle H. Emmelot‐Vonk, Pim A. de Jong(University Medical Center Utrecht), M-J Cramer(University Medical Center Utrecht)
Cited by 134
Related Papers
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.
|Stroke|1993|12.3k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
|European Heart Journal|2021|6.1k
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
|New England Journal of Medicine|2002|3.6k
Interpretation of the evidence for the efficacy and safety of statin therapy
|The Lancet|2016|1.8k